Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016 in China

SHANGHAI, China, July 12, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today the completion of study subjects enrollment in Phase I trial of SARS-CoV-2 neutralizing monoclonal antibody injection (Product Code: JS016), developed jointly with Institute of Microbiology, Chinese […]

Junshi Biosciences Announces Approval of “B” Marker Removal from Company’s Stock Name by HKEX

SHANGHAI, China, July 12, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that following its application to The Stock Exchange of Hong Kong Limited (HKEX) pursuant to Rule 18A.12 of the Rules Governing the Listing of Securities on […]

CORRECTED PRESS RELEASE: Seaborn Charts Course After Successful Emergence from Chapter 11 of Seabras-1 Entities

BOSTON, July 10, 2020 (GLOBE NEWSWIRE) — Following the successful emergence from Chapter 11 of Seabras-1 entities, leading subsea cable systems operator Seaborn, today announced the appointments of board members Pete Hayes and Don Shassian, as Interim CEO and Interim CFO, respectively. “We are excited about the future and sincerely thank all of our employees, customers, providers […]